Cytokinetics, Incorporated · NASDAQ:CYTK

Harrington Robert Arthur received 191 Cytokinetics, Incorporated shares as an award (Form 4)

Traded Apr 15, 2026 · Filed Apr 15, 2026

On Apr 15, 2026, Harrington Robert Arthur (Director) received 191 Cytokinetics, Incorporated shares as an award at US$65.37 for US$12,486, leaving 18,930 shares. Filed Apr 15, 2026 (Form 4).

Awarded
191 shares
Price
US$65.37
Value
US$12,486
Holding after
18,930 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 15, 2026Common StockAward191US$65.3718,930Direct

Source

View original at SEC

Related